The optimal antithrombotic regimen to prevent post-CABG adverse events: an ongoing controversy.
Publication
, Journal Article
Gurbel, PA; Navarese, EP; Tantry, US
Published in: Eur Heart J
August 1, 2019
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Eur Heart J
DOI
EISSN
1522-9645
Publication Date
August 1, 2019
Volume
40
Issue
29
Start / End Page
2441 / 2443
Location
England
Related Subject Headings
- Ticagrelor
- Myocardial Infarction
- Humans
- Fibrinolytic Agents
- Coronary Artery Bypass
- Cardiovascular System & Hematology
- Aspirin
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Gurbel, P. A., Navarese, E. P., & Tantry, U. S. (2019). The optimal antithrombotic regimen to prevent post-CABG adverse events: an ongoing controversy. Eur Heart J, 40(29), 2441–2443. https://doi.org/10.1093/eurheartj/ehz263
Gurbel, Paul A., Eliano P. Navarese, and Udaya S. Tantry. “The optimal antithrombotic regimen to prevent post-CABG adverse events: an ongoing controversy.” Eur Heart J 40, no. 29 (August 1, 2019): 2441–43. https://doi.org/10.1093/eurheartj/ehz263.
Gurbel PA, Navarese EP, Tantry US. The optimal antithrombotic regimen to prevent post-CABG adverse events: an ongoing controversy. Eur Heart J. 2019 Aug 1;40(29):2441–3.
Gurbel, Paul A., et al. “The optimal antithrombotic regimen to prevent post-CABG adverse events: an ongoing controversy.” Eur Heart J, vol. 40, no. 29, Aug. 2019, pp. 2441–43. Pubmed, doi:10.1093/eurheartj/ehz263.
Gurbel PA, Navarese EP, Tantry US. The optimal antithrombotic regimen to prevent post-CABG adverse events: an ongoing controversy. Eur Heart J. 2019 Aug 1;40(29):2441–2443.
Published In
Eur Heart J
DOI
EISSN
1522-9645
Publication Date
August 1, 2019
Volume
40
Issue
29
Start / End Page
2441 / 2443
Location
England
Related Subject Headings
- Ticagrelor
- Myocardial Infarction
- Humans
- Fibrinolytic Agents
- Coronary Artery Bypass
- Cardiovascular System & Hematology
- Aspirin
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences